Related Experiment Video
Updated: May 28, 2026

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Published on: March 2, 2020
Pyrrolamide DNA gyrase inhibitors: optimization of antibacterial activity and efficacy
Brian A Sherer1, Kenneth Hull, Oluyinka Green
1Infection Innovative Medicines Unit, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA. brian.sherer@astrazeneca.com
Abstract:
The pyrrolamides are a new class of antibacterial agents targeting DNA gyrase, an essential enzyme across bacterial species and inhibition results in the disruption of DNA synthesis and subsequently, cell death. The optimization of biochemical activity and other drug-like properties through substitutions to the pyrrole, piperidine, and heterocycle portions of the molecule resulted in pyrrolamides with improved cellular activity and in vivo efficacy.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Gene Regulation in Microbial Communities: Quorum Sensing
Antiviral Nucleoside Inhibitors

